Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,872 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.
Murata T, Aoki Y, Kato Y, Tanaka T, Araki R, Kato K, Hida K, Kawamura T, Yoshida K, Imamura Y, Toyonaga T, Yamada K, Sakane N; NHO T1DM Research Group. Murata T, et al. Among authors: imamura y. J Diabetes Sci Technol. 2017 Sep;11(5):1055-1056. doi: 10.1177/1932296817697330. J Diabetes Sci Technol. 2017. PMID: 28859515 Free PMC article. No abstract available.
Intensified outpatient nutrition management improves body weight and skeletal muscle loss after esophageal cancer surgery: a single-center, retrospective, single-arm clinical study.
Takahashi N, Okamura A, Ishii M, Moriya N, Yamaguchi A, Inamochi Y, Takagi K, Nakaya E, Kuriyama K, Terayama M, Tamura M, Kanamori J, Imamura Y, Saino Y, Watanabe M. Takahashi N, et al. Among authors: imamura y. Langenbecks Arch Surg. 2024 Nov 4;409(1):333. doi: 10.1007/s00423-024-03526-2. Langenbecks Arch Surg. 2024. PMID: 39489800 Free PMC article.
FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
Maruyama S, Imamura Y, Toihata T, Haraguchi I, Takamatsu M, Yamashita M, Nakashima Y, Oki E, Taguchi K, Yamamoto M, Mine S, Okamura A, Kanamori J, Nunobe S, Sano T, Kitano S, Noda T, Watanabe M. Maruyama S, et al. Among authors: imamura y. Cancer Sci. 2024 Oct 23. doi: 10.1111/cas.16373. Online ahead of print. Cancer Sci. 2024. PMID: 39440906 Free article.
Inflammation‑based prognostic markers in patients with advanced or recurrent gastric cancer treated with nivolumab: Tokushukai REAl‑world Data project 02 (TREAD 02).
Shimoyama R, Imamura Y, Uryu K, Mase T, Ohtaki M, Ohtani K, Shiragami M, Fujimura Y, Hayashi M, Shinozaki N, Minami H. Shimoyama R, et al. Among authors: imamura y. Mol Clin Oncol. 2024 Oct 3;21(6):90. doi: 10.3892/mco.2024.2788. eCollection 2024 Dec. Mol Clin Oncol. 2024. PMID: 39421231 Free PMC article.
1,872 results